Provided by Tiger Trade Technology Pte. Ltd.

GT Biopharma Inc.

0.4751
+0.00661.41%
Post-market: 0.47860.0035+0.74%19:51 EDT
Volume:1.03M
Turnover:484.86K
Market Cap:14.99M
PE:-0.08
High:0.4949
Open:0.4686
Low:0.4558
Close:0.4685
52wk High:3.85
52wk Low:0.3915
Shares:31.55M
Float Shares:30.72M
Volume Ratio:1.44
T/O Rate:3.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.2484
EPS(LYR):-6.9370
ROE:-1377.41%
ROA:-125.85%
PB:2.59
PE(LYR):-0.07

Loading ...

May 15, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Major Issues Report

Form 8-K - Current report
May 06, 2025

Major Issues Report

Form 8-K - Current report
Apr 14, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Apr 04, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Correspondence

Form CORRESP - Correspondence
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Feb 21, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 07, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 27, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 27, 2025

Major Issues Report

Form 8-K - Current report
Dec 23, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 28, 2024

Major Issues Report

Form 8-K - Current report
Nov 21, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 16, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 27, 2024

Correspondence

Form CORRESP - Correspondence
Jun 27, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]